Corbus Pharmaceuticals’ $94.5 Million Shares Public Offering

Laura Testa
Tagged:

Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction.Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the closing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here